PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Brigham and Women\'s Hospital and.\', \'Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.\', \'Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.\', \'Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.\', \'Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.\', \'Center for Cancer Research, Department of Medicine, and.\', \'Center for Bacterial Pathogenesis, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.\', \'Center for Immunology and Inflammatory Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1172/JCI148635148635
?:doi
?:hasPublicationType
?:journal
  • The Journal of clinical investigation
is ?:pmid of
?:pmid
?:pmid
  • 34196300
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all